View More Recent Stories

Feb 12, 2025 04:15PM Theralase(R) Demonstrates Effective Treatment of Herpes
Feb 10, 2025 07:00AM Theralase(R) Releases Latest Research on Inactivation of Herpes Simplex Viruses
Jan 27, 2025 04:15PM Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting
Dec 9, 2024 08:05AM Theralase(R) Launches Three New Clinical Study Sites in USA
Dec 5, 2024 07:00AM Theralase(R) Launches New Clinical Study Site in Canada
Nov 27, 2024 05:05PM Theralase(R) Release’s 3Q2024 Financial Statements
Nov 15, 2024 07:00AM Theralase(R) Closes Non-Brokered Private Placement
Nov 12, 2024 06:23PM Theralase(R) Extends Warrants
Oct 7, 2024 07:00AM Theralase(R) Provides Update on Bladder Cancer Clinical Study
Sep 24, 2024 05:00PM Theralase(R) Closes Non-Brokered Private Placement and Issues Stock Options
Sep 19, 2024 05:05PM Theralase(R) Extends Warrants
Sep 3, 2024 07:00AM Ruvidar(TM) Proven More Effective Than Acyclovir in Destruction of Herpes Simplex Virus
Aug 28, 2024 07:00AM Rutherrin(R) Increases Efficacy of Chemotherapy for Lung Cancer
Aug 21, 2024 07:00AM Theralase(R) Demonstrates Unique Ability to Activate Rutherrin(R) With Diabetes Drug
Aug 12, 2024 07:00AM Theralase(R) Release’s 2Q2024 Financial Statements
Jul 8, 2024 05:15PM Theralase(R) Closes $CAN 775,000 in First Tranche of Non-Brokered Private Placement
Jun 20, 2024 07:00AM Rutherrin(R) Repurposes Non-Cancer Drugs for Cancer Therapy
Jun 19, 2024 07:00AM Rutherrin(R) Demonstrates Complete Response in Lung Cancer Preclinically
Jun 19, 2024 07:00AM Rutherrin(R) Demonstrates Complete Response in Lung Cancer Preclinically
Jun 18, 2024 07:00AM Rutherrin(R) Increases Efficacy of Immunotherapy Preclinically
Jun 18, 2024 07:00AM Rutherrin(R) Increases Efficacy of Immunotherapy Preclinically
Jun 12, 2024 07:00AM Rutherrin(R) Increases Efficacy of Chemotherapy
Jun 12, 2024 07:00AM Rutherrin(R) Increases Efficacy of Chemotherapy
Jun 10, 2024 07:00AM Ruvidar(TM) Enhances Efficacy of Cancer Drug
View More Recent Stories